Total Payments
$4,921
2024 Payments
$903.48
Companies
30
Transactions
254
Medicare Patients
5,478
Medicare Billing
$558,564
Payment Breakdown by Category
Food & Beverage$4,744 (96.4%)
Education$176.49 (3.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,744 | 251 | 96.4% |
| Education | $176.49 | 3 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,224 | 72 | $0 (2024) |
| Galderma Laboratories, L.P. | $701.23 | 32 | $0 (2024) |
| LEO Pharma Inc. | $416.57 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $388.97 | 19 | $0 (2023) |
| Janssen Biotech, Inc. | $358.46 | 13 | $0 (2024) |
| Allergan, Inc. | $230.88 | 16 | $0 (2022) |
| GENZYME CORPORATION | $222.09 | 10 | $0 (2021) |
| PFIZER INC. | $220.80 | 21 | $0 (2024) |
| Incyte Corporation | $210.12 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $111.38 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $903.48 | 35 | ABBVIE INC. ($327.53) |
| 2023 | $663.13 | 31 | ABBVIE INC. ($280.76) |
| 2022 | $544.89 | 29 | ABBVIE INC. ($202.86) |
| 2021 | $408.91 | 19 | AbbVie Inc. ($94.66) |
| 2020 | $319.91 | 16 | Novartis Pharmaceuticals Corporation ($129.44) |
| 2019 | $531.95 | 30 | Allergan Inc. ($111.02) |
| 2018 | $434.40 | 27 | AbbVie, Inc. ($162.21) |
| 2017 | $1,114 | 67 | Galderma Laboratories, L.P. ($328.29) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: Immunology | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.79 | General |
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.03 | General |
| 08/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $99.55 | General |
| 07/31/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Dermatology | ||||||
| 07/30/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.30 | General |
| 07/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: DERMATOLOGY | ||||||
| 06/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.86 | General |
| 06/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: DERMATOLOGY | ||||||
| 05/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.22 | General |
| 05/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 05/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.89 | General |
| Category: Immunology | ||||||
| 04/30/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,352 | 2,225 | $350,098 | $148,636 |
| 2022 | 14 | 1,338 | 2,108 | $219,573 | $132,510 |
| 2021 | 19 | 1,599 | 2,603 | $251,820 | $162,189 |
| 2020 | 14 | 1,189 | 1,990 | $183,807 | $115,230 |
Total Patients
5,478
Total Services
8,926
Medicare Billing
$558,564
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 416 | $90,449 | $40,035 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 282 | 403 | $63,810 | $26,833 | 42.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 186 | 242 | $46,197 | $18,533 | 40.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 130 | 168 | $35,693 | $15,906 | 44.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 176 | 260 | $31,638 | $11,625 | 36.7% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 22 | 26 | $18,999 | $9,087 | 47.8% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 12 | 14 | $10,524 | $5,018 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $10,870 | $4,298 | 39.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 13 | $6,935 | $3,571 | 51.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 46 | 76 | $6,750 | $3,465 | 51.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 24 | 28 | $12,080 | $3,076 | 25.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 103 | 468 | $5,729 | $2,698 | 47.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $5,917 | $2,380 | 40.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 26 | $2,602 | $1,240 | 47.6% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 11 | $1,906 | $871.20 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 312 | 468 | $49,402 | $30,538 | 61.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 225 | 306 | $44,370 | $28,389 | 64.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 147 | 193 | $26,207 | $17,144 | 65.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 165 | 205 | $31,904 | $16,062 | 50.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 173 | 253 | $19,905 | $10,439 | 52.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 19 | 20 | $9,900 | $7,788 | 78.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $8,775 | $4,964 | 56.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2022 | 13 | 13 | $6,045 | $4,391 | 72.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 27 | 29 | $8,265 | $3,229 | 39.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 35 | 58 | $3,912 | $2,728 | 69.7% |
About Dr. Jill Javahery, M.D
Dr. Jill Javahery, M.D is a Specialist healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1568647022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Javahery, M.D has received a total of $4,921 in payments from pharmaceutical and medical device companies, with $903.48 received in 2024. These payments were reported across 254 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,744).
As a Medicare-enrolled provider, Javahery has provided services to 5,478 Medicare beneficiaries, totaling 8,926 services with total Medicare billing of $558,564. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Long Beach, CA
- Active Since 01/03/2008
- Last Updated 01/03/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1568647022
Products in Payments
- SKYRIZI (Biological) $459.02
- COSENTYX (Biological) $332.57
- ADBRY (Biological) $311.80
- Humira (Biological) $293.62
- RINVOQ (Biological) $235.58
- TREMFYA (Drug) $228.46
- EUCRISA (Drug) $203.81
- EPIDUO FORTE (Drug) $193.58
- SOOLANTRA (Drug) $173.49
- DERMATITIS - DISEASE (Drug) $152.79
- BOTOX COSMETIC (Biological) $151.98
- OPZELURA (Drug) $138.12
- LIBTAYO (Biological) $131.85
- Sotyktu (Drug) $111.38
- ENSTILAR (Drug) $100.27
- REMICADE (Biological) $76.68
- Erivedge (Biological) $49.08
- KERYDIN (Drug) $47.59
- HUMIRA (Biological) $42.66
- Seysara (Drug) $42.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Long Beach
David Morrison, M.d, M.D
Specialist — Payments: $4.9M
Specialist $4.9M
Peter Kurzweil, M.d, M.D
Specialist — Payments: $511,121
Specialist $511,121
Dan Tran, M.d, M.D
Specialist — Payments: $394,164
Specialist $394,164
Dr. David Shavelle, M.d, M.D
Specialist — Payments: $88,220
Specialist $88,220
Philip Yuan, M.d, M.D
Specialist — Payments: $59,461
Specialist $59,461
Dr. Nilesh Vora, M.d, M.D
Specialist — Payments: $18,049
Specialist $18,049